BioPharmaceutical Multi-Attribute Method (MAM) Symposia

2019 MAM Symposia

Confident, reproducible, and fast characterization of therapeutic proteins is critical for drug product quality and patient safety. The Multi-Attribute Method (MAM) is a mass spectrometry-based peptide mapping & monitoring workflow used to quantify a range of product quality attributes and detect new impurities simultaneously, in a single analytical protocol.

Attend a seminar to connect with industry experts in the Multi-Attribute Method from Symphogen; NIBRT; Sanofi; Novo Nordisk; and Thermo Fisher Scientific, network with users, and learn innovations in the workflow.  

• Learn how peptide monitoring using high resolution accurate mass (HRAM) mass spectrometry provides the necessary resolution of peptides and their modifications to afford confident measurement of potential critical quality attributes (CQAs)
• See how compliant-ready software delivers the necessary new peak detection to allow for flagging of untargeted differences
• Discover how MAM can be used from discovery through to manufacturing

Register